跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROACTIV+ PORE TARGETING SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PROACTIV+ PORE TARGETING SOLUTION
Authorized
STANDARD
PROACTIV+ PORE TARGETING SOLUTION
Alchemee LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cf15990cb4bbaed3
Company
Alchemee LLC
Type
Standard
Approval Details
Approval Id
cf15990cb4bbaed3
Drug Approval Canada Name
PROACTIV+ PORE TARGETING SOLUTION
Product Name
PROACTIV+ PORE TARGETING SOLUTION
Status
Marketed
Status Date
2022-09-15
Original Market Date
2014-06-20
Din
02411245
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:28.00
Atc Original
D10AE01 BENZOYL PEROXIDE
Atc Name
d 10 ae 01
Aig Number
0107205004
Company Name
Alchemee LLC
Company Address
3 Skyline Drive, 2nd Floor, Hawthorne, New York, United States, 10532
Company Detail Path
/organization/alchemee-llc
Company Information
Pharmaceutical Company Name
Alchemee LLC
Country Name
United States
Province Name
New York
City Name
hawthorne,new york,country_us
Address
3 Skyline Dr
Active Ingredients
BENZOYL PEROXIDE
2.5 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cf15990cb4bbaed3
Type
Standard
Back to Health Canada Approvals